We serve 10-(3-(naphthalen-2-yl)phenyl)anthracene-9-boronic acid CAS:853945-54-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Contact us for information like 10-(3-(naphthalen-2-yl)phenyl)anthracene-9-boronic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,10-[3-(2-Naphthalenyl)phenyl]-9-anthraceneboronic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,10-[3-(2-Naphthalenyl)phenyl]-9-anthraceneboronic acid Use and application,10-[3-(2-Naphthalenyl)phenyl]-9-anthraceneboronic acid technical grade,usp/ep/jp grade.
Related News: Therefore, the growth of the global pharmaceutical market has greatly affected the development of the entire intermediate and API industry.3-Methacryloxypropylmethyldimethoxysilane manufacturer Therefore, the growth of the global pharmaceutical market has greatly affected the development of the entire intermediate and API industry.1-Iodo-5-fluoropentane supplier If the drug is in a syrup form, then the excipient is the liquid that has been used to make it as such.5-Methyl-1,3-benzenediacetonitrile vendor If the drug is in a syrup form, then the excipient is the liquid that has been used to make it as such.Characteristic APIs represented by cardiovascular, antiviral, antitumor and other categories are targeted at generic APIs with patent expiring original research drugs, which have high scientific and technological content and rich profits. They have developed in China in the past decade. The more active API segment has contributed to the rise of Huahai Pharmaceutical, Chuangnuo Pharmaceutical, and Jiangbei Pharmaceutical.
